PCS-2023 > 3 > 3E > 3E0 > 3E0H |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E0H | Introduction, Lower GI | |
3E0H3 | Percutaneous | |
3E0H30 | Antineoplastic | |
3E0H304 | Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Percutaneous Approach | |
3E0H305 | Introduction of Other Antineoplastic into Lower GI, Percutaneous Approach | |
3E0H30M | Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Percutaneous Approach | |
3E0H32 | Anti-infective | |
3E0H328 | Introduction of Oxazolidinones into Lower GI, Percutaneous Approach | |
3E0H329 | Introduction of Other Anti-infective into Lower GI, Percutaneous Approach | |
3E0H33 | Anti-inflammatory | |
3E0H33Z | Introduction of Anti-inflammatory into Lower GI, Percutaneous Approach | |
3E0H36 | Nutritional Substance | |
3E0H36Z | Introduction of Nutritional Substance into Lower GI, Percutaneous Approach | |
3E0H37 | Electrolytic and Water Balance Substance | |
3E0H37Z | Introduction of Electrolytic and Water Balance Substance into Lower GI, Percutaneous Approach | |
3E0H3B | Anesthetic Agent | |
3E0H3BZ | Introduction of Anesthetic Agent into Lower GI, Percutaneous Approach | |
3E0H3H | Radioactive Substance | |
3E0H3HZ | Introduction of Radioactive Substance into Lower GI, Percutaneous Approach | |
3E0H3K | Other Diagnostic Substance | |
3E0H3KZ | Introduction of Other Diagnostic Substance into Lower GI, Percutaneous Approach | |
3E0H3N | Analgesics, Hypnotics, Sedatives | |
3E0H3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Lower GI, Percutaneous Approach | |
3E0H3T | Destructive Agent | |
3E0H3TZ | Introduction of Destructive Agent into Lower GI, Percutaneous Approach | |
3E0H3G | Other Therapeutic Substance | |
3E0H3GC | Introduction of Other Therapeutic Substance into Lower GI, Percutaneous Approach | |
3E0H3S | Gas | |
3E0H3SF | Introduction of Other Gas into Lower GI, Percutaneous Approach | |
3E0H7 | Via Natural or Artificial Opening | |
3E0H70 | Antineoplastic | |
3E0H704 | Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Via Natural or Artificial Opening | |
3E0H705 | Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening | |
3E0H70M | Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening | |
3E0H72 | Anti-infective | |
3E0H728 | Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening | |
3E0H729 | Introduction of Other Anti-infective into Lower GI, Via Natural or Artificial Opening | |
3E0H73 | Anti-inflammatory | |
3E0H73Z | Introduction of Anti-inflammatory into Lower GI, Via Natural or Artificial Opening | |
3E0H76 | Nutritional Substance | |
3E0H76Z | Introduction of Nutritional Substance into Lower GI, Via Natural or Artificial Opening | |
3E0H77 | Electrolytic and Water Balance Substance | |
3E0H77Z | Introduction of Electrolytic and Water Balance Substance into Lower GI, Via Natural or Artificial Opening | |
3E0H7B | Anesthetic Agent | |
3E0H7BZ | Introduction of Anesthetic Agent into Lower GI, Via Natural or Artificial Opening | |
3E0H7H | Radioactive Substance | |
3E0H7HZ | Introduction of Radioactive Substance into Lower GI, Via Natural or Artificial Opening | |
3E0H7K | Other Diagnostic Substance | |
3E0H7KZ | Introduction of Other Diagnostic Substance into Lower GI, Via Natural or Artificial Opening | |
3E0H7N | Analgesics, Hypnotics, Sedatives | |
3E0H7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Lower GI, Via Natural or Artificial Opening | |
3E0H7T | Destructive Agent | |
3E0H7TZ | Introduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening | |
3E0H7G | Other Therapeutic Substance | |
3E0H7GC | Introduction of Other Therapeutic Substance into Lower GI, Via Natural or Artificial Opening | |
3E0H7S | Gas | |
3E0H7SF | Introduction of Other Gas into Lower GI, Via Natural or Artificial Opening | |
3E0H8 | Via Natural or Artificial Opening Endoscopic | |
3E0H80 | Antineoplastic | |
3E0H804 | Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H805 | Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H80M | Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H82 | Anti-infective | |
3E0H828 | Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H829 | Introduction of Other Anti-infective into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H83 | Anti-inflammatory | |
3E0H83Z | Introduction of Anti-inflammatory into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H86 | Nutritional Substance | |
3E0H86Z | Introduction of Nutritional Substance into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H87 | Electrolytic and Water Balance Substance | |
3E0H87Z | Introduction of Electrolytic and Water Balance Substance into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H8B | Anesthetic Agent | |
3E0H8BZ | Introduction of Anesthetic Agent into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H8H | Radioactive Substance | |
3E0H8HZ | Introduction of Radioactive Substance into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H8K | Other Diagnostic Substance | |
3E0H8KZ | Introduction of Other Diagnostic Substance into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H8N | Analgesics, Hypnotics, Sedatives | |
3E0H8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H8T | Destructive Agent | |
3E0H8TZ | Introduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H8G | Other Therapeutic Substance | |
3E0H8GC | Introduction of Other Therapeutic Substance into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H8S | Gas | |
3E0H8SF | Introduction of Other Gas into Lower GI, Via Natural or Artificial Opening Endoscopic | |
3E0H4 | Percutaneous Endoscopic | |
3E0H4G | Other Therapeutic Substance | |
3E0H4GC | Introduction of Other Therapeutic Substance into Lower GI, Percutaneous Endoscopic Approach |
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |